Krishna Institute of Medical Sciences (KIMS) Stock Overview
Provides medical and health care services under the KIMS Hospitals brand in India. More details
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 6/6 |
| Past Performance | 1/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
KIMS Community Fair Values
See what 24 others think this stock is worth. Follow their fair value or set your own to get alerts.
Krishna Institute of Medical Sciences Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹640.80 |
| 52 Week High | ₹798.40 |
| 52 Week Low | ₹474.05 |
| Beta | -0.13 |
| 1 Month Change | -4.37% |
| 3 Month Change | -11.79% |
| 1 Year Change | 7.00% |
| 3 Year Change | 115.76% |
| 5 Year Change | n/a |
| Change since IPO | 221.38% |
Recent News & Updates
Krishna Institute of Medical Sciences' (NSE:KIMS) Solid Earnings May Rest On Weak Foundations
Nov 18Here's Why We Think Krishna Institute of Medical Sciences (NSE:KIMS) Is Well Worth Watching
Nov 11Recent updates
Shareholder Returns
| KIMS | IN Healthcare | IN Market | |
|---|---|---|---|
| 7D | -2.4% | 0.3% | 1.4% |
| 1Y | 7.0% | 5.1% | 2.7% |
Return vs Industry: KIMS exceeded the Indian Healthcare industry which returned 5.1% over the past year.
Return vs Market: KIMS exceeded the Indian Market which returned 2.7% over the past year.
Price Volatility
| KIMS volatility | |
|---|---|
| KIMS Average Weekly Movement | 3.7% |
| Healthcare Industry Average Movement | 4.7% |
| Market Average Movement | 5.2% |
| 10% most volatile stocks in IN Market | 8.5% |
| 10% least volatile stocks in IN Market | 3.1% |
Stable Share Price: KIMS has not had significant price volatility in the past 3 months compared to the Indian market.
Volatility Over Time: KIMS's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1973 | 5,264 | Abhinay Bollineni | www.kimshospitals.com |
Krishna Institute of Medical Sciences Limited provides medical and health care services under the KIMS Hospitals brand in India. The company offers neurology, neurosurgery, psychiatry, and neuro rehabilitation; cardiology, cardiac and vascular surgery, heart transplant, and cardio rehabilitation; and pulmonology, interventional pulmonology, thoracic surgery, and lung transplant. It also provides medical and surgical gastroenterology, hepatobiliary pancreatic surgery, liver transplant, and bariatric surgery; ear, nose, throat, and head and neck surgery; and nephrology, urology, andrology, renal transplant, gynecology, urogynecology, IVF and art, fetal medicine, and obstetrics.
Krishna Institute of Medical Sciences Limited Fundamentals Summary
| KIMS fundamental statistics | |
|---|---|
| Market cap | ₹256.41b |
| Earnings (TTM) | ₹3.36b |
| Revenue (TTM) | ₹34.02b |
Is KIMS overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| KIMS income statement (TTM) | |
|---|---|
| Revenue | ₹34.02b |
| Cost of Revenue | ₹13.82b |
| Gross Profit | ₹20.20b |
| Other Expenses | ₹16.84b |
| Earnings | ₹3.36b |
Last Reported Earnings
Sep 30, 2025
Next Earnings Date
n/a
| Earnings per share (EPS) | 8.40 |
| Gross Margin | 59.39% |
| Net Profit Margin | 9.88% |
| Debt/Equity Ratio | 97.5% |
How did KIMS perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/12/23 02:48 |
| End of Day Share Price | 2025/12/23 00:00 |
| Earnings | 2025/09/30 |
| Annual Earnings | 2025/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Krishna Institute of Medical Sciences Limited is covered by 33 analysts. 16 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Nitin Bhasin | Ambit Capital |
| Ashwin Mehta | Ambit Capital |
| Prashant Nair | Ambit Capital |



